FOMAT Medical Research, an industry leader in fostering diversity in clinical research, has partnered with Golden Valley Health Centers (GVHC), one of the largest nonprofit healthcare providers in Central and Northern California, to offer clinical trial opportunities and advanced treatment options to underserved communities. This alliance will bring innovative clinical research directly to over 160,000 patients across San Joaquin, Stanislaus and Merced counties, improving access to cutting-edge therapies and striving for equitable healthcare.

GVHC, serving a highly diverse community that includes Hispanic, Asian, Black, and American Indian patients, is integrating clinical research into its comprehensive care model for the first time. This partnership enables both organizations to reach traditionally underrepresented groups in clinical trials, bringing advanced treatment options to communities often without access to groundbreaking research and innovative therapies.

Through this partnership, FOMAT and GVHC aim to provide high-quality clinical research as a care option, focusing on populations that are often underrepresented in clinical studies. By combining GVHC’s community trust and extensive reach with FOMAT’s expertise in diverse patient recruitment and optimized clinical operations, this collaboration will support studies across areas such as pediatrics, women’s health, geriatrics, and behavioral health, delivering impactful healthcare advancements where they are needed most.

“Partnering with Golden Valley Health Centers, an organization deeply committed to quality healthcare, aligns with our mission to expand diverse clinical research options in underserved communities,” said Nicholas Focil, CEO of FOMAT Medical Research. “This collaboration is a vital step in ensuring that all communities, particularly those often overlooked, have access to innovative therapies that can make a real difference.”

“Golden Valley Health Centers’ partnership with FOMAT Medical Research introduces an essential new facet of care for our patients,” said David Quackenbush, President and CEO of GVHC. “Incorporating clinical research into our healthcare services furthers our mission of delivering high-quality healthcare for all and allows us to provide our patients access to the latest advancements in medicine.”

FOMAT Medical Research is a pioneering clinical research site network based in California, committed to enhancing patient outcomes through diverse and innovative clinical studies.

Golden Valley Health Centers (GVHC) is a nonprofit organization serving nearly 200,000 patients annually across 47 locations, providing primary care to underserved populations throughout Central and Northern California.